I was diagnosed with a gleason 7 (3+4) and PSA 5 which was biopsied twice and several MRIs and then HIFU last december when PSA was 8 - very unusually I am told a previously twice negative biopsy lesion on the clear side suddenly comes up as gleason 9 (4+5) after a PSA of 7.
I am now on bicalutimide 150mg and as i had polio which has left me with lots of muscle loss from that as well as affecting my respiratory muscles the idea of using bicalutimide (casodex) as a mono-therapy alone to shrink the cancer and lower PSA prior to radiotherapy without risking the LHRH hormmes such as zoladex seems an a reasonable option choice.
I am aware that the usual treatment would be to use both or at least start with the bicalutimide,and then add the zoladex LHRH this impacting both paths of testosterone. The PSMA scan shows no evidence of spread outside the prostate, which i think is not absolute evidence but perhaps 85% accurate even with a gleason 9.
I wondered if anyone had experience of this and what the outcome was, obviously its not easy to make decisions but I am reluctant to compromise my walking and functioning by adding the zolodex if ut the relative benefits are marginal - obviously if i were 80+ i might be less concerned but at 71 and still working part-time it is less clear given a 10 year plus horizon.
Hi
I was on Prostap rather than Zoladex but believe that it will affect you in a similar way. The biggest problem I see is that the HT will cause muscle wastage and loss of strength.
There are others here who have been on Zoladex and, I'm sure they can confirm, or challenge my thoughts.
My understanding is that the Bicalutamide is used to prevent tumour flare prior to HT and is not a therapy in its own right.
Regards
Stuart
Stuart is correct, I was going Bicalutamide for 4weeks to prevent cancer flare, prior to starting HT, I'm on Enzalutamide 4 table's per day and Decapeptyl injection every 24 weeks, mussel and bone problems can occur, but I've not experienced them yet, there are plenty of other side effects but manageable.
Try talking to your oncologist about different treatment path's before you make a decision.
All the best Ulls
Whatever cancer throws your way, we’re right there with you.
We’re here to provide physical, financial and emotional support.
© Macmillan Cancer Support 2025 © Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 3rd Floor, Bronze Building, The Forge, 105 Sumner Street, London, SE1 9HZ. VAT no: 668265007